Log in

LON:GSKGlaxoSmithKline News Headlines

GBX 1,661.80
-10.00 (-0.60 %)
(As of 06/2/2020 01:46 AM ET)
Add
Compare
Today's Range
1,654.40
Now: GBX 1,661.80
1,691.60
50-Day Range
1,544.20
MA: GBX 1,654.49
1,729.98
52-Week Range
1,328.19
Now: GBX 1,661.80
1,857
Volume6.72 million shs
Average Volume9.12 million shs
Market Capitalization£83.37 billion
P/E Ratio15.53
Dividend Yield4.57%
BetaN/A

Headlines

GlaxoSmithKline (LON GSK) News Headlines

Source:
DateHeadline
Somewhat Positive News Coverage Extremely Likely to Affect GlaxoSmithKline (LON:GSK) Share PriceSomewhat Positive News Coverage Extremely Likely to Affect GlaxoSmithKline (LON:GSK) Share Price
www.americanbankingnews.com - May 30 at 7:43 AM
Gilead Continues to Build Cancer FranchiseGilead Continues to Build Cancer Franchise
finance.yahoo.com - May 29 at 7:44 PM
GlaxoSmithKline (GSK) Gains As Market Dips: What You Should Know - Yahoo FinanceGlaxoSmithKline (GSK) Gains As Market Dips: What You Should Know - Yahoo Finance
finance.yahoo.com - May 28 at 11:21 PM
GlaxoSmithKline (LON:GSK) Earns Hold Rating from Liberum CapitalGlaxoSmithKline (LON:GSK) Earns Hold Rating from Liberum Capital
www.americanbankingnews.com - May 28 at 6:01 AM
The GSK share price is beating the FTSE 100: should you keep buying?The GSK share price is beating the FTSE 100: should you keep buying?
www.msn.com - May 24 at 1:36 PM
£1K to invest? I’d buy AstraZeneca or GSK pharma shares for a rich retirement£1K to invest? I’d buy AstraZeneca or GSK pharma shares for a rich retirement
www.fool.co.uk - May 24 at 1:36 PM
GlaxoSmithKline (LON:GSK) Given News Impact Rating of 2.29GlaxoSmithKline (LON:GSK) Given News Impact Rating of 2.29
www.americanbankingnews.com - May 22 at 3:54 PM
GlaxoSmithKline Teams Up With Mammoth Biosciences on a CRISPR-Based COVID-19 Test - Motley FoolGlaxoSmithKline Teams Up With Mammoth Biosciences on a CRISPR-Based COVID-19 Test - Motley Fool
www.fool.com - May 21 at 2:58 PM
GSK highlights scientific innovation and advances in its growing oncology portfolio at ASCO 2020GSK highlights scientific innovation and advances in its growing oncology portfolio at ASCO 2020
www.prnewswire.com - May 20 at 2:11 PM
GlaxoSmithKline (LON:GSK) Given a GBX 1,920 Price Target at UBS GroupGlaxoSmithKline (LON:GSK) Given a GBX 1,920 Price Target at UBS Group
www.americanbankingnews.com - May 20 at 1:32 PM
Global Anti-viral Drug Market (2020 to 2025) - Featuring Gilead Sciences, GlaxoSmithKline & Bristol-Myers Squibb Among Others - GlobeNewswireGlobal Anti-viral Drug Market (2020 to 2025) - Featuring Gilead Sciences, GlaxoSmithKline & Bristol-Myers Squibb Among Others - GlobeNewswire
www.globenewswire.com - May 20 at 9:10 AM
Better Buy: GlaxoSmithKline vs. Pfizer - Motley FoolBetter Buy: GlaxoSmithKline vs. Pfizer - Motley Fool
www.fool.com - May 20 at 9:10 AM
GlaxoSmithKline plc (LON:GSK) Receives Consensus Recommendation of "Hold" from AnalystsGlaxoSmithKline plc (LON:GSK) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - May 20 at 2:34 AM
GlaxoSmithKline: Solid Prospects In The Vaccine Race - Seeking AlphaGlaxoSmithKline: Solid Prospects In The Vaccine Race - Seeking Alpha
seekingalpha.com - May 19 at 6:09 PM
GlaxoSmithKline (LON:GSK) Given a GBX 2,060 Price Target at Goldman Sachs GroupGlaxoSmithKline (LON:GSK) Given a GBX 2,060 Price Target at Goldman Sachs Group
www.americanbankingnews.com - May 18 at 12:20 PM
3 ETFs in Focus as Race for Vaccine Intensifies3 ETFs in Focus as Race for Vaccine Intensifies
finance.yahoo.com - May 18 at 10:30 AM
Positive Media Coverage Somewhat Likely to Impact GlaxoSmithKline (LON:GSK) Share PricePositive Media Coverage Somewhat Likely to Impact GlaxoSmithKline (LON:GSK) Share Price
www.americanbankingnews.com - May 17 at 3:34 AM
Trump Taps Former GlaxoSmithKline Exec For Warp Speed COVID-19 Vaccine Initiative - Motley FoolTrump Taps Former GlaxoSmithKline Exec For 'Warp Speed' COVID-19 Vaccine Initiative - Motley Fool
www.fool.com - May 15 at 6:55 PM
Inside the Science and Companies Racing to Develop a Covid-19 VaccineInside the Science and Companies Racing to Develop a Covid-19 Vaccine
finance.yahoo.com - May 15 at 6:55 PM
Pluralsight, Stanley Black Decker, Gilead, Regeneron and GlaxoSmithKline as Zacks Bull and Bear of the DayPluralsight, Stanley Black Decker, Gilead, Regeneron and GlaxoSmithKline as Zacks Bull and Bear of the Day
finance.yahoo.com - May 14 at 2:18 PM
GlaxoSmithKline's Relative Strength Rating Flashes Healthy SignsGlaxoSmithKline's Relative Strength Rating Flashes Healthy Signs
finance.yahoo.com - May 14 at 2:18 PM
Sanofi CEO Says Americans to Get Potential Virus Vaccine FirstSanofi CEO Says Americans to Get Potential Virus Vaccine First
finance.yahoo.com - May 14 at 9:17 AM
GlaxoSmithKline (LON:GSK) Price Target Raised to GBX 1,920 at UBS GroupGlaxoSmithKline (LON:GSK) Price Target Raised to GBX 1,920 at UBS Group
www.americanbankingnews.com - May 14 at 6:27 AM
GlaxoSmithKline plc (LON:GSK) Insider Buys £118.51 in StockGlaxoSmithKline plc (LON:GSK) Insider Buys £118.51 in Stock
www.americanbankingnews.com - May 13 at 2:53 PM
Novavax Soars on Coronavirus Vaccine Funding: ETFs to GainNovavax Soars on Coronavirus Vaccine Funding: ETFs to Gain
finance.yahoo.com - May 13 at 8:14 AM
3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline - InvestorPlace3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline - InvestorPlace
www.investorplace.com - May 8 at 3:29 PM
Pharma Companies Have To Hit A Bull's-Eye To Launch Coronavirus Vaccine In 2021Pharma Companies Have To Hit A Bull's-Eye To Launch Coronavirus Vaccine In 2021
finance.yahoo.com - May 8 at 3:29 PM
GSK tests experimental drug to treat pneumonia from COVID-19GSK tests experimental drug to treat pneumonia from COVID-19
finance.yahoo.com - May 7 at 12:15 PM
Akebia Shares Climb on Positive Anemia Drug Study ResultsAkebia Shares Climb on Positive Anemia Drug Study Results
finance.yahoo.com - May 7 at 12:15 PM
UPDATE 1-GSK selling $3.45 bln stake in Hindustan Unilever -term sheetUPDATE 1-GSK selling $3.45 bln stake in Hindustan Unilever -term sheet
www.reuters.com - May 7 at 7:13 AM
Britains GSK to sell entire stake in Hindustan UnileverBritain's GSK to sell entire stake in Hindustan Unilever
finance.yahoo.com - May 7 at 7:13 AM
GSK To Sell Entire Stake In Hindustan UnileverGSK To Sell Entire Stake In Hindustan Unilever
www.nasdaq.com - May 7 at 7:13 AM
GSK sells $3.35 billion stake in Hindustan UnileverGSK sells $3.35 billion stake in Hindustan Unilever
finance.yahoo.com - May 7 at 7:12 AM
Britain's GSK to sell entire stake in Hindustan UnileverBritain's GSK to sell entire stake in Hindustan Unilever
finance.yahoo.com - May 7 at 7:12 AM
Top 20 Vaccine Companies In-Depth Analysis, 2020 - Featuring Sanofi Pasteur, GlaxoSmithKline & Pfizer Among Others - ResearchAndMarkets.com - Yahoo FinanceTop 20 Vaccine Companies In-Depth Analysis, 2020 - Featuring Sanofi Pasteur, GlaxoSmithKline & Pfizer Among Others - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - May 1 at 8:52 AM
BRIEF-Glaxosmithkline Says Cos Zejula Approved In First-Line Ovarian Cancer - ReutersBRIEF-Glaxosmithkline Says Co's Zejula Approved In First-Line Ovarian Cancer - Reuters
www.reuters.com - April 30 at 5:20 AM
Edited Transcript of GSK.L earnings conference call or presentation 29-Apr-20 1:00pm GMT - Yahoo FinanceEdited Transcript of GSK.L earnings conference call or presentation 29-Apr-20 1:00pm GMT - Yahoo Finance
finance.yahoo.com - April 30 at 12:19 AM
GlaxoSmithKline: FDA Approves SNDA For Zejula - Quick Facts - NasdaqGlaxoSmithKline: FDA Approves SNDA For Zejula - Quick Facts - Nasdaq
www.nasdaq.com - April 30 at 12:19 AM
Edited Transcript of GSK.L earnings conference call or presentation 29-Apr-20 1:00pm GMTEdited Transcript of GSK.L earnings conference call or presentation 29-Apr-20 1:00pm GMT
finance.yahoo.com - April 30 at 12:19 AM
TOP NEWS: GlaxoSmithKline Profit Gets Covid-19... - MorningstarTOP NEWS: GlaxoSmithKline Profit Gets Covid-19... - Morningstar
www.morningstar.co.uk - April 29 at 7:18 PM
U.S. FDA gives broader approval to GSK's Zejula for ovarian cancerU.S. FDA gives broader approval to GSK's Zejula for ovarian cancer
finance.yahoo.com - April 29 at 7:18 PM
FDA approves Zejula (niraparib) as the only once-daily PARP inhibitor in first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer regardless of biomarker statusFDA approves Zejula (niraparib) as the only once-daily PARP inhibitor in first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer regardless of biomarker status
finance.yahoo.com - April 29 at 7:18 PM
GlaxoSmithKline plc (GSK) Q1 2020 Earnings Call TranscriptGlaxoSmithKline plc (GSK) Q1 2020 Earnings Call Transcript
finance.yahoo.com - April 29 at 7:18 PM
GlaxoSmithKline plans to sell stake in Unilevers India unit - Bloomberg News - NasdaqGlaxoSmithKline plans to sell stake in Unilever's India unit - Bloomberg News - Nasdaq
www.nasdaq.com - April 29 at 2:16 PM
GlaxoSmithKline Shingrix sales up 81% in Q1; guidance affirmed - Seeking AlphaGlaxoSmithKline Shingrix sales up 81% in Q1; guidance affirmed - Seeking Alpha
seekingalpha.com - April 29 at 9:16 AM
Glaxo (GSK) Beats Earnings & Revenue Estimates in Q1Glaxo (GSK) Beats Earnings & Revenue Estimates in Q1
finance.yahoo.com - April 29 at 9:16 AM
GSK boss sees no coronavirus vaccine mass-produced before mid-2021GSK boss sees no coronavirus vaccine mass-produced before mid-2021
finance.yahoo.com - April 29 at 9:16 AM
Better Buy: Inovio Pharmaceuticals vs. GlaxoSmithKline - Motley FoolBetter Buy: Inovio Pharmaceuticals vs. GlaxoSmithKline - Motley Fool
www.fool.com - April 28 at 8:13 AM
GSK Presents New Data from the GARNET Study Demonstrating Potential of Dostarlimab to Treat a Subset of Women with Recurrent or Advanced Endometrial CancerGSK Presents New Data from the GARNET Study Demonstrating Potential of Dostarlimab to Treat a Subset of Women with Recurrent or Advanced Endometrial Cancer
finance.yahoo.com - April 23 at 10:39 PM
Italian Respiratory Devices Industry Assessment 2020 with Bayer, ResMed, Chiesi Farmaceutici, GlaxoSmithKline, Novartis, and Boehringer Ingelheim Dominating - Yahoo FinanceItalian Respiratory Devices Industry Assessment 2020 with Bayer, ResMed, Chiesi Farmaceutici, GlaxoSmithKline, Novartis, and Boehringer Ingelheim Dominating - Yahoo Finance
finance.yahoo.com - April 21 at 4:46 PM
This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.